Frontlight ResearchEarly access
Trial site
Beijing
- 8running trials
- 2closed trials
The trials here
What the 10 trials at this site are about, from their registry records.
- Conditions
- CIDP (chronic inflammatory demyelinating polyneuropathy)3 trials
- Multiple sclerosis3 trials
- Bronchiectasis1 trial
- Chronic rhinosinusitis with nasal polyps1 trial
- COPD1 trial
- Cystic fibrosis1 trial
- Fabry disease1 trial
- Phase
- Phase 39 trials
- Phase 21 trial
- Status
- Active, not recruiting4 trials
- Recruiting3 trials
- Completed2 trials
- Enrolling by invitation1 trial
- Lead sponsor
- Sanofi10 trials
Running trials
Recruiting
Recruiting
Enrolling by invitation
Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDP
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- CIDP (chronic inflammatory demyelinating polyneuropathy)2 recruiting
- COPD1 recruiting
- Multiple sclerosis1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 18 Nov 2026